Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Engert

Showing results (71-80 of 379) with videos related to

Pageof 38
Sort By:
Journal of the National Cancer Institute|July 31, 2008
Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemiaChristine Herbst, Ina Monsef, Nicole Skötz, et al.
The Cochrane Database of Systematic Reviews|June 17, 2014
The role of additional radiotherapy for primary central nervous system lymphomaJonas Zacher, Benjamin Kasenda, Andreas Engert, et al.
Journal of the National Cancer Institute|April 7, 2005
Second biannual report of the Cochrane Haematological Malignancies GroupThilo Kober, Julia Bohlius, Sven Trelle, et al.
Hemasphere|November 15, 2019
Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative MedicinesAnton Hagenbeek, Andreas Engert, Peter Kapitein, et al.
British Journal of Haematology|July 25, 2003
Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic reviewJulia Bohlius, Marcel Reiser, Guido Schwarzer, et al.
European Journal of Haematology. Supplementum|July 13, 2005
Current treatment strategies of the German Hodgkin Study Group (GHSG)Beate Klimm, Volker Diehl, Beate Pfistner, et al.
Hemasphere|February 20, 2020
Open Access is the Plan S Way Forward in Hematology ResearchJan Cools, Andreas Engert, John Gribben, et al.
Onkologie|March 4, 2006
Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximabMarkus Jensen, Thomas Elter, Andreas Engert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2020
Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma NichePaul J Bröckelmann, Sven Borchmann, Peter Borchmann, et al.
Haematologica|November 26, 2016
The emerging role of immune checkpoint inhibition in malignant lymphomaIda Hude, Stephanie Sasse, Andreas Engert, et al.
Pageof 38

Showing results (71-80 of 379) with videos related to

Sort By:
Pageof 38
Journal of the National Cancer Institute|July 31, 2008
Eighth biannual report of the Cochrane Haematological Malignancies Group--focus on chronic lymphatic leukemiaChristine Herbst, Ina Monsef, Nicole Skötz, et al.
The Cochrane Database of Systematic Reviews|June 17, 2014
The role of additional radiotherapy for primary central nervous system lymphomaJonas Zacher, Benjamin Kasenda, Andreas Engert, et al.
Journal of the National Cancer Institute|April 7, 2005
Second biannual report of the Cochrane Haematological Malignancies GroupThilo Kober, Julia Bohlius, Sven Trelle, et al.
Hemasphere|November 15, 2019
Affordability of Medicines a Top Priority for EHA: Toward a Fair Pricing Model for Innovative MedicinesAnton Hagenbeek, Andreas Engert, Peter Kapitein, et al.
British Journal of Haematology|July 25, 2003
Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic reviewJulia Bohlius, Marcel Reiser, Guido Schwarzer, et al.
European Journal of Haematology. Supplementum|July 13, 2005
Current treatment strategies of the German Hodgkin Study Group (GHSG)Beate Klimm, Volker Diehl, Beate Pfistner, et al.
Hemasphere|February 20, 2020
Open Access is the Plan S Way Forward in Hematology ResearchJan Cools, Andreas Engert, John Gribben, et al.
Onkologie|March 4, 2006
Prolonged remission in a patient with relapsed follicular lymphoma after a single course of rituximabMarkus Jensen, Thomas Elter, Andreas Engert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2020
Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma NichePaul J Bröckelmann, Sven Borchmann, Peter Borchmann, et al.
Haematologica|November 26, 2016
The emerging role of immune checkpoint inhibition in malignant lymphomaIda Hude, Stephanie Sasse, Andreas Engert, et al.
Pageof 38